Efficacy and safety of canagliflozin monotherapy in Japanese patients with type 2 diabetes inadequately controlled with diet and exercise: a 24-week, randomized, double-blind, placebo-controlled, Phase III study
Year: 2014
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Institutions: Kyoto University, Tanabe Pharma Corporation (Japan)
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2087539094
